Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Not applicable Interventional Accepts healthy volunteers Results available

Evaluation of Chagas Blood Screening and Confirmatory Assays

ClinicalTrials.gov ID: NCT00718042

Public ClinicalTrials.gov record NCT00718042. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 12, 2026, 8:12 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Evaluation of ABBOTT PRISM Chagas Assay and Chagas Confirmatory Assay

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Protocol designed to test blood samples from blood donors of whole blood and blood components using a new investigational screening test (PRISM Chagas) that detects antibody to T. cruzi (Chagas infection). Results will be compared to the current T. cruzi antibody screening assay. Specimens positive with the screening assay will be further tested with a new investigational Chagas confirmatory assay \[Enzyme Strip Assay (ESA) Chagas\]. Additional specimens collected under separate protocols or sourced from suppliers will also be provided to the clinical sites for testing with PRISM Chagas assay and ESA Chagas.

Study identification

NCT ID
NCT00718042
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Lead sponsor
Abbott Diagnostics Division
Industry
Enrollment
41,862 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2008
Primary completion
Jun 30, 2009
Completion
Aug 31, 2009
Last update posted
Mar 6, 2012

2008 – 2009

United States locations

U.S. sites
7
U.S. states
6
U.S. cities
7
Facility City State ZIP Site status
BloodNet USA Lakeland Florida 33805
Florida Blood Services St. Petersburg Florida 33716
LifeSource Blood Center Glenview Illinois 60025
American Red Cross Charlotte NTL Charlotte North Carolina 28273
American Red Cross Portland Oregon 97220
Rhode Island Blood Center Providence Rhode Island 02908
South Texas Blood and Tissue Center San Antonio Texas 78201

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Recently updated Healthy trials

Other public records listing Healthy. Sorted by last update posted; newest first. Not a recommendation.

All Healthy trials →

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00718042, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 6, 2012 · Synced Sep 12, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00718042 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →